Omega Healthcare Investors Files 8-K

TL;DR

OHI filed an 8-K on May 1st covering financials and operations.

AI Summary

Omega Healthcare Investors, Inc. filed an 8-K on May 1, 2025, reporting on its Results of Operations and Financial Condition, and including Financial Statements and Exhibits. The filing details the company's financial performance and provides supporting documentation. No specific dollar amounts or significant events beyond routine reporting were detailed in the provided excerpt.

Why It Matters

This filing provides investors with updated financial information and disclosures about Omega Healthcare Investors' operational and financial status.

Risk Assessment

Risk Level: low — The filing appears to be routine financial reporting without immediate significant events or negative disclosures.

Key Players & Entities

• OMEGA HEALTHCARE INVESTORS, INC. (company) — Registrant
• May 1, 2025 (date) — Date of earliest event reported
• Maryland (jurisdiction) — State of incorporation
• 383041398 (identifier) — IRS Employer Identification No.
• 303 International Circle, Suite 200 Hunt Valley, Maryland 21030 (address) — Principal executive offices
• 410-427-1700 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0000888491-25-000013.txt : 20250501 0000888491-25-000013.hdr.sgml : 20250501 20250501161827 ACCESSION NUMBER: 0000888491-25-000013 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20250501 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250501 DATE AS OF CHANGE: 20250501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] ORGANIZATION NAME: 05 Real Estate & Construction EIN: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 25903387 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 ohi-20250501x8k.htm 8-K OMEGA HEALTHCARE INVESTORS, INC._May 1, 2025 0000888491 false 0000888491 2025-05-01 2025-05-01 ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _______________ ​ FORM 8-K _______________ ​ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ​ Date of Report (Date of earliest event reported): May 1, 2025 ​ OMEGA HEALTHCARE INVESTORS, INC. (Exact name of registrant as specified in its charter) ​ Maryland 1-11316 38-3041398 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.) ​ 303 International Circle, Suite 200 Hunt Valley , Maryland 21030 (Address of principal executive offices / Zip Code) ​ ( 410 ) 427-1700 (Registrant’s telephone number, including area code) ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐      Written communications pursuant to Rule 425 under the Securities Act. ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act. ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act. Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934: ​ Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.10 par value OHI New York Stock Exchange ​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ​ Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ​ ​ Item 2.02     Regulation FD Disclosure ​ On May 1, 2025, Omega Healthcare Investors, Inc. (“Omega”) issued a press release regarding its financial results for the quarter and year ended March 31, 2025. Omega’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. ​ The information in this Item 2.02 of this Current Report on Form 8-K and the Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise s